Infinity Pharmaceuticals Inc
OTC:INFIQ

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
OTC:INFIQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 91 USD
Have any thoughts about
Infinity Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one INFIQ stock under the Base Case scenario is 29.044 USD. Compared to the current market price of 0.0001 USD, Infinity Pharmaceuticals Inc is Undervalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INFIQ Relative Value
Base Case
29.044 USD
Undervaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
Median 3Y
0.1
Median 5Y
0.3
Industry
8.1
Forward
0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
23.9
Forward
-0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
22.7
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
26.3
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
2.6
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-18.2
Industry
8
Forward
-6.4
vs History
vs Industry
Median 3Y
-23.2
Median 5Y
-41.9
Industry
9.3
vs History
0
vs Industry
Median 3Y
0.6
Median 5Y
1
Industry
4.5
vs History
0
vs Industry
Median 3Y
0.6
Median 5Y
1
Industry
4.1
Forward
0.4
vs History
0
vs Industry
Median 3Y
0.6
Median 5Y
1.1
Industry
6.1
vs History
0
vs Industry
Median 3Y
0.6
Median 5Y
1
Industry
3.8
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-9.1
Industry
4.8

Multiples Across Competitors

INFIQ Competitors Multiples
Infinity Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Infinity Pharmaceuticals Inc
OTC:INFIQ
91 USD 0 -0 0.4 0.4
US
Abbvie Inc
NYSE:ABBV
358.9B USD 6.5 68 16.5 25.2
US
Amgen Inc
NASDAQ:AMGN
172.7B USD 5.6 55.2 19.5 35.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.8B USD 11.9 -250.7 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
110.7B USD 4 105.2 9.9 12.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 932.8 -493.2 -537.1 -522.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
92B USD 6.8 21.3 18.2 20.2
AU
CSL Ltd
ASX:CSL
138.7B AUD 6.2 34.5 21.2 26.5
US
Seagen Inc
F:SGT
39.3B EUR 18.6 -57.1 -61.4 -55.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
34.2B USD 14.6 -469.3 206.3 317.6
NL
argenx SE
XBRU:ARGX
32B EUR 17.9 -125.6 -100.7 -73.4
P/E Multiple
Earnings Growth
US
Infinity Pharmaceuticals Inc
OTC:INFIQ
Average P/E: 56.8
Not Available
N/A
US
Abbvie Inc
NYSE:ABBV
68
406%
US
Amgen Inc
NASDAQ:AMGN
55.2
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
105.2
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493.2 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.3
56%
AU
CSL Ltd
ASX:CSL
34.5
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -469.3 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -125.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Infinity Pharmaceuticals Inc
OTC:INFIQ
Average EV/EBITDA: 39.8
0.4
N/A
US
Abbvie Inc
NYSE:ABBV
16.5
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
37%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -537.1 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
53%
AU
CSL Ltd
ASX:CSL
21.2
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
206.3
N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -100.7 N/A

See Also

Discover More
Back to Top